logo

For the Inventor, By the Inventor

Durham, NC, United States of America

Suresh De Silva

This inventor holds 14 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Heat Biologics, Inc., Heat Biologies, Inc., Kopfkino IP, LLC. Active years: 2018-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Suresh De Silva. Retrieved from https://idiyas.com/inventor/suresh-de-silva-mwtq14kl

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 14 

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.2

ph-index = 3

Forward Citations = 35(Granted Patents)


Company Filing History:

goldMedal12 out of 15 
 
Heat Biologics, Inc.
 patents
silverMedal1 out of 1 
 
Heat Biologies, Inc.
 patent
bronzeMedal1 out of 1 
 
Kopfkino IP, LLC
 patent

Years Active: 2018-2024

Loading Chart...
Loading Chart...
14 patents (USPTO):Explore Patents
1. 12178847 - Compositions and methods for adjoining type I and type II extracellular domains as heterologous chimeric proteins (2024-12-31),
2. 11654180 - Compositions and methods for adjoining type I and type II extracellular domains as heterologous chimeric proteins (2023-05-23),
3. 11548930 - Intratumoral vaccination (2023-01-10),
4. 11547742 - Compositions and methods for adjoining type I and type II extracellular domains as heterologous chimeric proteins (2023-01-10),
5. 10660936 - Compositions and methods for adjoining type I and type II extracellular domains as heterologous chimeric proteins (2020-05-26),
6. 10653748 - Compositions and methods for adjoining type I and type II extracellular domains as heterologous chimeric proteins (2020-05-19),
7. 10646545 - Compositions and methods for adjoining type I and type II extracellular domains as heterologous chimeric proteins (2020-05-12),
8. 10543253 - Compositions and methods for adjoining type I and type II extracellular domains as heterologous chimeric proteins (2020-01-28),
9. 10525102 - Compositions and methods for adjoining type I and type II extracellular domains as heterologous chimeric proteins (2020-01-07),
10. 10493128 - Compositions and methods for adjoining type I and type II extracellular domains as heterologous chimeric proteins (2019-12-03),
11. 10449233 - Compositions and methods for adjoining type I and type II extracellular domains as heterologous chimeric proteins (2019-10-22),
12. 10188701 - Compositions and methods for adjoining type I and type II extracellular domains as heterologous chimeric proteins (2019-01-29),
13. 10183060 - Compositions and methods for adjoining type I and type II extracellular domains as heterologous chimeric proteins (2019-01-22),
14. 10086042 - Compositions and methods for adjoining type I and type II extracellular domains as heterologous chimeric proteins (2018-10-02),

Title: Suresh De Silva: Innovator in Chimeric Protein Technologies

Introduction

Suresh De Silva is a prominent inventor based in Durham, NC (US). He has made significant contributions to the field of biotechnology, particularly in the development of chimeric proteins for therapeutic applications. With a total of 14 patents, his work focuses on innovative solutions for treating diseases, including cancer and autoimmune disorders.

Latest Patents

One of Suresh De Silva's latest patents is titled "Compositions and methods for adjoining type I and type II extracellular domains as heterologous chimeric proteins." This invention relates to compositions and methods that include chimeric proteins designed for use in immunotherapies targeting cancer and autoimmunity. The invention provides various embodiments of fusions of extracellular domains of transmembrane proteins, which can exhibit either stimulatory or inhibitory effects.

Career Highlights

Throughout his career, Suresh has worked with notable companies such as Heat Biologics, Inc. and Heat Biologies, Inc. His expertise in the field has allowed him to develop groundbreaking technologies that have the potential to transform therapeutic approaches in medicine.

Collaborations

Suresh has collaborated with esteemed colleagues, including Taylor H Schreiber and George Fromm. These partnerships have further enhanced his research and development efforts in the biotechnology sector.

Conclusion

Suresh De Silva is a distinguished inventor whose work in chimeric protein technologies is paving the way for innovative treatments in healthcare. His contributions are vital in the ongoing fight against complex diseases, showcasing the importance of innovation in biotechnology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…